Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

Using the right study materials can help strengthen the skills required to crack technical interviews in 2026. They aid in strengthening problem-solving skills, ...

By Joseph Tulloch For years, AI safety experts have been warning of a future moment where AI models become advanced enough to ...

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...

We are approaching the integration of artificial intelligence into our universities in a piecemeal rather than a comprehensive fashion.

AI development is often framed as a race among countries, companies and academic researchers. But figuring out who’s actually ...

Running a local DNS server is great - until your devices ignore it ...

Here's Why. Ethereum remains a focal point for institutional on-chain activity even as price momentum stalls. In 2026, Ether has retreated about 36% for the year, slipping back from the $3,000 milesto ...

"If you love trains, you understand the big difference between knowing a train is due soon and actually seeing the massive ...

By now, you’ve perhaps heard of looksmaxxers, the young men pursuing extreme physical transformation in the belief that appearance is the sole determinant of social and sexual success. If not, I’m ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...